T2 Biosystems, Inc.
(NASDAQ:TTOO)
$0.09
-0.08 (-48.25%)
At Close: 4:00 PM
$0.12
0.03 (27.78%)
Pre Market: 5:19 AM
TTOO Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
TTOO Stock Price Today
T2 Biosystems, Inc. (TTOO) stock declined over -48.25% intraday to trade at $0.09 a share on NASDAQ. The stock opened with a loss of -2.07% at $0.17 and touched an intraday high of $0.17, falling -48.25% against the last close of $0.17. The T2 Biosystems, Inc. in stock market went to a low of $0.10 during the session.
TTOO Stock Snapshot
$0.17
Prev. Close
5.37 Million
Market Cap
$0.10
Day Low
$0.17
Open
20.28 Million
Number of Shares
$0.17
Day High
N/A
P/E ratio
-14.26
EPS (TTM)
0.41
Cash Flow per Share
2.50
Free Float in %
-2.45
Book Value
31785894.00
Volume
TTOO Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 2023-02-14 | $1.15 | $1.18 | $1.07 | $1.08 | 2528681.00 |
| 2023-02-13 | $1.42 | $1.42 | $1.36 | $1.40 | 3630000.00 |
| 2023-02-10 | $1.43 | $1.45 | $1.40 | $1.41 | 47700.00 |
| 2023-02-08 | $1.60 | $1.60 | $1.49 | $1.51 | 98566.00 |
| 2023-02-07 | $1.50 | $1.59 | $1.38 | $1.58 | 178800.00 |
| 2023-02-06 | $1.42 | $1.50 | $1.40 | $1.48 | 220000.00 |
| 2023-02-03 | $1.47 | $1.47 | $1.40 | $1.40 | 219077.00 |
| 2023-02-02 | $1.51 | $1.59 | $1.33 | $1.42 | 679100.00 |
| 2023-02-01 | $1.61 | $1.69 | $1.49 | $1.51 | 218600.00 |
| 2023-01-31 | $1.60 | $1.63 | $1.49 | $1.57 | 133700.00 |
Contact Details
Company Information
Employees158.00
Beta0.33
Sales or Revenue$17.15 Million
5Y Sales Change36.70%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryDiagnostics & Research
About Company
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida, a direct-from-blood test that identifies blood stream infections that causes sepsis and candidemia; T2Bacteria, a direct-from-blood test, which detects bacterial pathogens associated with sepsis; T2Resistance to identify carbapenem resistance genes; and T2SARS-CoV-2 panel to detect SARS-CoV-2 virus. In addition, it is developing T2Biothreat for detection of biothreat pathogens; comprehensive sepsis panel to detect bloodstream infections caused by bacterial and Candida species, and antibiotic resistant markers; T2Cauris to provide direct detection of the emerging superbug Candida auris in patient skin, patient blood, and hospital environmental samples; and T2Lyme, a direct-from-blood test panel designed to run on the T2Dx Instrument to identify the bacteria that cause Lyme disease. The company has collaboration agreements with Canon U.S. Life Sciences, Inc. to develop a diagnostic test panel to detect Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Frequently Asked Questions
What is the current T2 Biosystems, Inc. (TTOO) stock price?
T2 Biosystems, Inc. (NASDAQ: TTOO) stock price is $0.09 in the last trading session. During the trading session, TTOO stock reached the peak price of $0.17 while $0.10 was the lowest point it dropped to. The percentage change in TTOO stock occurred in the recent session was -48.25% while the dollar amount for the price change in TTOO stock was -$0.08.
TTOO's industry and sector of operation?
The NASDAQ listed TTOO is part of Diagnostics & Research industry that operates in the broader Healthcare sector. T2 Biosystems, Inc. , an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally.
Who are the executives of TTOO?
Mr. John J. Sperzel III, B.Sc.
Pres, Chief Executive Officer & Chairman
Mr. Alec J. Barclay
Senior Vice President & Chief Operating Officer
Dr. Roger Smith Ph.D.
Senior Vice President of Science R&D
Mr. Michael Terrence Gibbs Esq.
Senior Vice President & Gen. Counsel
How TTOO did perform over past 52-week?
TTOO's closing price is 0.04% higher than its 52-week low of $0.0977 where as its distance from 52-week high of $15 is -0.99%.
How many employees does TTOO have?
Number of TTOO employees currently stands at 158.00. TTOO operates from 101 Hartwell Avenue</br>Lexington, MA 02421</br>US.
Link for TTOO official website?
Official Website of TTOO is: https://www.t2biosystems.com
How do I contact TTOO?
TTOO could be contacted at phone #781 761 4646 and can also be accessed through its website. TTOO operates from 101 Hartwell Avenue</br>Lexington, MA 02421</br>US.
How many shares of TTOO are traded daily?
TTOO stock volume for the day was 31785894.00 shares. The average number of TTOO shares traded daily for last 3 months was 651.22 Thousands.
What is the market cap of TTOO currently?
The market value of TTOO currently stands at $5.37 Million with its latest stock price at $0.09 and 20.28 Million of its shares outstanding.